| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c7f53df76ce0d57caee2df5a281c5fe |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
| filingDate |
2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_450887482d72bb3ca8a1cd832c168e4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21b2a2dc70dd0fdc97ecd1aa159e6e6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a1cc8a06e859a8d5ab544f2149358aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18458b218d4beed9e371a40c968dab31 |
| publicationDate |
2019-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110290781-A |
| titleOfInvention |
Dosage forms for controlled release at specific sites in the gastrointestinal tract |
| abstract |
The present disclosure provides a drug dosage form for controlled release at a specific part of the gastrointestinal tract. The pharmaceutical dosage form comprises a housing defining a first compartment and a second compartment, a first pharmaceutically active ingredient located in the first compartment and a second pharmaceutically active ingredient located in the second compartment, wherein the first pharmaceutically active ingredient and the The second pharmaceutically active ingredients can be the same or different. The housing comprises a first material that is soluble at a first gastrointestinal site and a second material that is soluble at a second gastrointestinal site. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023020504-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111110754-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115006362-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115531554-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115531554-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111493103-A |
| priorityDate |
2017-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |